GDC-0834 T11379
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GDC-0834 inhibits BTK with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 _M in mouse and rat, respectively.�GDC-0834 is a potent and selective BTK inhib
CAS nr:
1133432-49-1
Purity:
98%
Molecular Weight:
596,74
SMILES:
O=C(C1=CC(CCCC2)=C2S1)NC3=CC=CC(C(N=C4NC5=CC=C([C@H]6N(C)CCN(C)C6=O)C=C5)=CN(C)C4=O)=C3C
Formula:
C33H36N6O3S
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors
Target:
BTK,BTK
